Marshall Wace, LLP Bio Rad Laboratories, Inc. Transaction History

Marshall Wace, LLP

  • $81.7 Billion
  • Q2 2025

A detailed history of Marshall Wace, LLP transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 926 shares of BIO stock, worth $295,903. This represents 0.0% of its overall portfolio holdings.

Number of Shares
926
Previous 27,095 96.58%
Holding current value
$295,903
Previous $6.6 Million 96.62%
% of portfolio
0.0%
Previous 0.01%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025
SELL
$216.56 - $256.68 $5.67 Million - $6.72 Million
-26,169 Reduced 96.58%
926 $223,000
Q1 2025

May 15, 2025
BUY
$243.0 - $367.0 $6.03 Million - $9.11 Million
24,816 Added 1088.9%
27,095 $6.6 Million
Q4 2024

Feb 13, 2025
BUY
$313.15 - $374.28 $713,668 - $852,984
2,279 New
2,279 $748,000
Q4 2023

Feb 14, 2024
SELL
$269.37 - $365.04 $32.1 Million - $43.6 Million
-119,350 Reduced 94.99%
6,300 $2.03 Million
Q3 2023

Nov 14, 2023
BUY
$350.25 - $422.63 $37.1 Million - $44.8 Million
106,037 Added 540.65%
125,650 $45 Million
Q2 2023

Aug 14, 2023
SELL
$359.49 - $486.4 $4.94 Million - $6.69 Million
-13,749 Reduced 41.21%
19,613 $7.44 Million
Q1 2023

May 15, 2023
BUY
$418.69 - $503.0 $13.7 Million - $16.5 Million
32,767 Added 5507.06%
33,362 $16 Million
Q4 2022

Feb 14, 2023
SELL
$351.71 - $456.01 $60.5 Million - $78.4 Million
-172,005 Reduced 99.66%
595 $250,000
Q3 2022

Nov 14, 2022
SELL
$412.59 - $563.26 $21.5 Million - $29.4 Million
-52,169 Reduced 23.21%
172,600 $72 Million
Q2 2022

Aug 15, 2022
SELL
$463.67 - $597.16 $112 Million - $145 Million
-242,574 Reduced 51.9%
224,769 $111 Million
Q1 2022

May 16, 2022
BUY
$524.57 - $735.42 $70.3 Million - $98.5 Million
133,973 Added 40.19%
467,343 $263 Million
Q4 2021

Feb 14, 2022
SELL
$708.84 - $794.68 $75.1 Million - $84.2 Million
-105,974 Reduced 24.12%
333,370 $252 Million
Q3 2021

Nov 15, 2021
BUY
$657.71 - $825.77 $2.79 Million - $3.51 Million
4,245 Added 0.98%
439,344 $328 Million
Q2 2021

Aug 13, 2021
SELL
$576.64 - $649.04 $77.2 Million - $86.9 Million
-133,819 Reduced 23.52%
435,099 $280 Million
Q1 2021

May 17, 2021
BUY
$547.01 - $662.35 $109 Million - $132 Million
199,507 Added 54.01%
568,918 $325 Million
Q4 2020

Feb 16, 2021
BUY
$510.68 - $643.45 $45.4 Million - $57.2 Million
88,844 Added 31.67%
369,411 $215 Million
Q3 2020

Nov 16, 2020
BUY
$454.43 - $535.6 $21.6 Million - $25.4 Million
47,465 Added 20.36%
280,567 $145 Million
Q2 2020

Aug 13, 2020
BUY
$334.87 - $493.06 $40.5 Million - $59.6 Million
120,850 Added 107.66%
233,102 $105 Million
Q1 2020

May 15, 2020
BUY
$320.01 - $409.07 $35.6 Million - $45.6 Million
111,393 Added 12967.75%
112,252 $39.4 Million
Q4 2019

Feb 14, 2020
SELL
$319.73 - $374.2 $24.9 Million - $29.1 Million
-77,897 Reduced 98.91%
859 $318,000
Q3 2019

Nov 14, 2019
BUY
$304.55 - $345.24 $17.4 Million - $19.8 Million
57,281 Added 266.73%
78,756 $26.2 Million
Q2 2019

Aug 14, 2019
BUY
$286.93 - $312.59 $6.16 Million - $6.71 Million
21,475 New
21,475 $6.71 Million
Q1 2019

May 14, 2019
SELL
$224.3 - $317.41 $2.06 Million - $2.92 Million
-9,196 Closed
0 $0
Q4 2018

Feb 14, 2019
SELL
$220.1 - $309.0 $3.25 Million - $4.56 Million
-14,767 Reduced 61.62%
9,196 $2.14 Million
Q3 2018

Nov 14, 2018
BUY
$289.28 - $326.15 $6.03 Million - $6.8 Million
20,850 Added 669.77%
23,963 $7.5 Million
Q2 2018

Aug 14, 2018
BUY
$244.1 - $303.88 $759,883 - $945,978
3,113 New
3,113 $898,000

Others Institutions Holding BIO

# of Institutions
438
Shares Held
19.2M
Call Options Held
10.7K
Put Options Held
35.5K
View Full List

About BIO-RAD LABORATORIES, INC.

BIO Quotes by TradingView
  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $7.87B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email